Point72 Asset Management, L.P. - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 99 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$71,052
-80.6%
26,512
-60.8%
0.00%
-100.0%
Q4 2022$367,068
-95.8%
67,600
-83.1%
0.00%
-97.4%
Q2 2021$8,773,000
+143.2%
399,844
+166.7%
0.04%
+129.4%
Q1 2021$3,607,000
+2674.6%
149,936
+1982.4%
0.02%
+1600.0%
Q4 2020$130,000
-94.9%
7,200
-93.1%
0.00%
-93.8%
Q2 2020$2,527,000
-51.9%
104,157
-13.8%
0.02%
-23.8%
Q2 2018$5,253,000
-36.7%
120,865
-46.0%
0.02%
-40.0%
Q1 2018$8,299,000
+109.1%
224,000
+12.0%
0.04%
+105.9%
Q4 2017$3,968,000200,0000.02%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders